Key Highlights

  • Second-quarter revenue grew 35% year over year, driven by Sustainable Ingredients.
  • Craig Wichner was named CEO on June 8.
  • New EU rules treat crops without added foreign DNA like conventional crops.
  • Third-quarter results are estimated for November 12.

Cibus, Inc. (NASDAQ:CBUS) has a market capitalisation of about $118 million. The plant-trait company is early-stage and loss-making, so its funding, leadership and regulatory backdrop are central.

Latest Company Context

Second-quarter 2026 results, released August 13, showed revenue growth of 35% year over year driven by Sustainable Ingredients, with cost discipline reducing operating expenses and net loss. Trailing revenue is $4.35 million and net loss $98.19 million (EPS -$1.58); 2025 revenue was $3.64 million with losses of $127.09 million.

Other items: Craig Wichner was named CEO on June 8; a collaboration with Crystal Crop Protection on India's mustard crop was announced September 28; a Q1 summary cited a $37 million capital raise and a U.S. rice launch delayed to 2029; a $200 million mixed shelf registration was filed; and the Portnoy Law Firm announced an investigation in April.

Key Business Drivers

Cibus develops gene-edited traits. Revenue is small against its losses, so cash runway and further financing, which could dilute shareholders, are key. On June 17 the company said new EU rules treat crops without added foreign DNA like conventional crops, which it sees as a new pathway; the commercial impact is not yet quantified.

Three analysts rate the stock Buy with an average target of $14.33.

What Investors Should Watch

Third-quarter results are estimated for November 12. Investors may watch cash balance, operating expenses, any use of the shelf registration, progress on rice and sustainable ingredients, and early outcomes of the India collaboration.

Regulatory Tailwinds Meet a Funding Question

Cibus offers regulatory tailwinds from the new EU rules but faces funding risk, with revenue still small against its losses. Cash runway and any use of the shelf registration are the figures to track into November.